Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Liu, Jonathan T.C. | Loewke, Nathan O. | Mandella, Michael J. | Levenson, Richard M. | Crawford, James M. | Contag, Christopher H.
Affiliations: Stony Brook University (SUNY) Department of Biomedical Engineering, Stony Brook, NY, USA | Clark Center for Biomed. Eng. and Science, Stanford University School of Medicine, Stanford, CA, USA | Brighton Consulting Group, Brighton, MA, USA | Department of Pathology and Laboratory Medicine, Hofstra North Shore-LIJ School of Medicine and North Shore-Long Island Jewish Health System, Lake Success, NY, USA
Note: [] Corresponding author: Jonathan T.C. Liu, Bioengineering G15, Stony Brook, NY 11794, USA. Tel.: +1 631 632 1727 (W) and +1 631 632 3222 (F); E-mail: [email protected]
Abstract: Advances in optical designs are enabling the development of miniature microscopes that can examine tissue in situ for early anatomic and molecular indicators of disease, in real time, and at cellular resolution. These new devices will lead to major changes in how diseases are detected and managed, driving a shift from today's diagnostic paradigm of biopsy followed by histopathology and recommended therapy, to non-invasive point-of-care diagnosis with possible same-session definitive treatment. This shift may have major implications for the training requirements of future physicians to enable them to interpret real-time in vivo microscopic data, and will also shape the emerging fields of telepathology and telemedicine. Implementation of new technologies into clinical practice is a complex process that requires bridging gaps between clinicians, engineers and scientists. This article provides a forward-looking discussion of these issues, with a focus on malignant and pre-malignant lesions, by first highlighting some of the clinical areas where point-of-care in vivo microscopy could address unmet needs, and then by reviewing the technological challenges that are being addressed, or need to be addressed, for in vivo microscopy to become a standard clinical tool.
Keywords: In vivo microscopy, molecular imaging, biomedical optics, microendoscopy, endomicroscopy, optical sectioning, optical biopsy, biomarker, cancer, dysplasia, image-guided therapy, telepathology
DOI: 10.3233/ACP-2011-011
Journal: Analytical Cellular Pathology, vol. 34, no. 3, pp. 81-98, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]